WebModerate Buy. 2 Ratings. 2 Buy. 0 Hold. 0 Sell. Based on 2 analysts giving stock ratings to . Orchard. Therapeutics. in the past 3 months . TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months. ORTX Stock 12 Months Forecast. WebYou can buy or sell ONTX and other ETFs, options, and stocks. About ONTX Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. CEO Steven M. Fruchtman
Onconova Therapeutics, Inc. (ONTX) Upgraded to Buy: What Does …
WebHe uses 7h timeframe, which is close to one day. This is the case study: I had a question from a trader who asked me about how to filter the noise around the many buy and sell … Web11 de abr. de 2024 · Neovasc Price Performance. Shares of NASDAQ NVCN opened at $30.03 on Tuesday. The stock has a market cap of $82.28 million, a P/E ratio of -1.99 and a beta of 1.70. Neovasc has a twelve month low ... citic securities international linkedin
Onconova Therapeutics (ONTX) Stock Forecast & Price Target
WebOut of 3 analysts, 2 ( 66.67%) are recommending ONTX as a Strong Buy, 0 ( 0%) are recommending ONTX as a Buy, 1 ( 33.33%) are recommending ONTX as a Hold, 0 ( … WebMotley Fool +23.77%. Feb-16-21 04:03PM. Onconova Therapeutics, Inc. Announces Closing of $28.75 Million Public Offering of Common Stock Including Full Exercise of the Over-Allotment Option. GlobeNewswire +5.17%. WebOut of 2 analysts, 1 ( 50%) are recommending MOTS as a Strong Buy, 1 ( 50%) are recommending MOTS as a Buy, 0 ( 0%) are recommending MOTS as a Hold, 0 ( 0%) are recommending MOTS as a Sell, and 0 ( 0%) are recommending MOTS as a Strong Sell. If you're new to stock investing, here's how to buy Motus Gi Holdings stock. What is … citic securities co ltd a share